Medical Countermeasures Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection by Global Biodefense 2 Apr 2020
Medical Countermeasures JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic by Global Biodefense 1 Apr 2020
Medical Countermeasures Mapping Risks to the Drug Supply Chain During COVID-19 Pandemic: Critical Shortages Likely in U.S. by Global Biodefense 28 Mar 2020
Medical Countermeasures 5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus by Global Biodefense 25 Mar 2020
Medical Countermeasures WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment by Global Biodefense 25 Mar 2020
Medical Countermeasures FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients by Global Biodefense 24 Mar 2020
Medical Countermeasures Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? by Global Biodefense 21 Mar 2020
Medical Countermeasures Using Antibodies from COVID-19 Survivors to Protect Healthcare Workers and Patients by Global Biodefense 13 Mar 2020
Medical Countermeasures XJTLU Research Indicates No Clinical Benefit for Corticosteroid Treatment of COVID-19 by Global Biodefense 13 Mar 2020
Medical Countermeasures AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies by Global Biodefense 12 Mar 2020
Medical Countermeasures Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine by Global Biodefense 2 Mar 2020
Medical Countermeasures Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S. by Global Biodefense 25 Feb 2020
Medical Countermeasures University of Queensland COVID-19 Vaccine Goes Into Test Production by Global Biodefense 23 Feb 2020
Medical Countermeasures Tulane National Primate Research Center Launches Coronavirus Research Program by Global Biodefense 21 Feb 2020
Medical Countermeasures HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine by Global Biodefense 18 Feb 2020
Medical Countermeasures J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics by Global Biodefense 18 Feb 2020
Medical Countermeasures Remdesivir Prevents MERS Coronavirus Disease in Monkeys by Global Biodefense 13 Feb 2020
CBRNE Army Medical Department Board Tests Nerve Agent Antidote Auto-Injectors by Global Biodefense 11 Feb 2020
